Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Glutathione Bioresponsive Cyclodextrin Nanosponges

Glutathione Bioresponsive Cyclodextrin Nanosponges Cyclodextrin‐based nanosponges are designed as new nanostructured material for drug delivery. In vitro and in vivo studies show that nanosponges can increase the effectiveness of anti‐cancer drugs encapsulated within their nanostructure. Reported is a new, cheap glutathione (GSH)‐responsive material easily obtained in high yield through a one‐step synthetic route. Effectiveness of this GSH‐responsive material was proved using several tumor cells and doxorubicin as model anticancer drug. The release of the drug was in according with the GSH content in tumor cells. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png ChemPlusChem Wiley

Loading next page...
 
/lp/wiley/glutathione-bioresponsive-cyclodextrin-nanosponges-LAOmFfPU6F

References (25)

Publisher
Wiley
Copyright
© 2016 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
ISSN
2192-6506
eISSN
2192-6506
DOI
10.1002/cplu.201500531
Publisher site
See Article on Publisher Site

Abstract

Cyclodextrin‐based nanosponges are designed as new nanostructured material for drug delivery. In vitro and in vivo studies show that nanosponges can increase the effectiveness of anti‐cancer drugs encapsulated within their nanostructure. Reported is a new, cheap glutathione (GSH)‐responsive material easily obtained in high yield through a one‐step synthetic route. Effectiveness of this GSH‐responsive material was proved using several tumor cells and doxorubicin as model anticancer drug. The release of the drug was in according with the GSH content in tumor cells.

Journal

ChemPlusChemWiley

Published: May 1, 2016

Keywords: ; ; ; ;

There are no references for this article.